Subbu Nambi
Stock Analyst at Guggenheim
(3.15)
# 1,132
Out of 4,876 analysts
38
Total ratings
48.15%
Success rate
2.89%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Buy | $122 → $114 | $94.71 | +20.37% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $36.27 | +37.85% | 2 | May 6, 2025 | |
| DHR Danaher | Reiterates: Buy | $250 | $199.81 | +25.12% | 1 | Apr 23, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $7.44 | +34.50% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $54.13 | +10.84% | 2 | Apr 11, 2025 | |
| NEOG Neogen | Maintains: Buy | $15 → $13 | $4.76 | +173.11% | 2 | Apr 10, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $5.29 | - | 2 | Apr 9, 2025 | |
| VCYT Veracyte | Maintains: Buy | $45 → $37 | $27.52 | +34.45% | 3 | Apr 9, 2025 | |
| TEM Tempus AI | Reiterates: Buy | n/a | $67.55 | - | 2 | Feb 25, 2025 | |
| BRKR Bruker | Reiterates: Buy | n/a | $41.55 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $51.15 | +9.49% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $168.56 | +18.65% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $48.30 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.10 | +93.55% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.77 | +683.49% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $11.43 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $123.94 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $20.46 | +22.19% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.27 | - | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.33 | - | 1 | Dec 14, 2023 |
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $94.71
Upside: +20.37%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $36.27
Upside: +37.85%
Danaher
Apr 23, 2025
Reiterates: Buy
Price Target: $250
Current: $199.81
Upside: +25.12%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $7.44
Upside: +34.50%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $54.13
Upside: +10.84%
Neogen
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $4.76
Upside: +173.11%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.29
Upside: -
Veracyte
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $27.52
Upside: +34.45%
Tempus AI
Feb 25, 2025
Reiterates: Buy
Price Target: n/a
Current: $67.55
Upside: -
Bruker
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $41.55
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $51.15
Upside: +9.49%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $168.56
Upside: +18.65%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $48.30
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.10
Upside: +93.55%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.77
Upside: +683.49%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $11.43
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $123.94
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $20.46
Upside: +22.19%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.27
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.33
Upside: -